Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 13Breast Neoplasms 11Obesity 8Motor Activity 7Malnutrition 7Colorectal Neoplasms 6Prostatic Neoplasms 5Overweight 5Lung Neoplasms 4Hypertension 4Weight Loss 3Stroke 3Stomach Neoplasms 3Pancreatic Neoplasms 3Heart Failure 3Diabetes Mellitus 3Cardiovascular Diseases 3Sarcopenia 2Polycystic Ovary Syndrome 2Osteoporosis 2Kidney Diseases 2Inflammation 2Heart Diseases 2Gastrointestinal Neoplasms 2Frailty 2Endometrial Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Cachexia 2Arthritis 2

Interventions

Carboplatin 156Paclitaxel 154Bevacizumab 96Cyclophosphamide 61Gemcitabine 46olaparib 45Cisplatin 45Topotecan 44niraparib 40liposomal doxorubicin 40pembrolizumab 38Surveys and Questionnaires 33Filgrastim 31Hyperthermic Intraperitoneal Chemotherapy 29Docetaxel 27Taxes 25Blood Specimen Collection 24fludarabine 23Drug Therapy 23Cytoreduction Surgical Procedures 23Peripheral Blood Stem Cell Transplantation 21Etoposide 21Doxorubicin 21Magnetic Resonance Spectroscopy 20durvalumab 17Specimen Handling 17Albumin-Bound Paclitaxel 17Immunoglobulin G 15Disulfides 15Letrozole 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ovarian Neoplasms × Nutrition Assessment × Clear all
NCT01439659 2026-01-16

Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
75 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡